Afuco™ Anti-Human CD63 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-CD63 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-CD63 antibodies target a calcium-independent pathway of antigen receptor regulation that is accessible to engagement by membrane proteins and on which novel therapeutic approaches to allergic diseases can be based.
Supplier Creative Biolabs
Product # AFC-128CL
Pricing Inquiry
Host Human
Target CD63
Species Reactivity Human
Type ADCC enhanced antibody
Storage ≤6 months at 4°C; ≥6 months at -20°C.
Feedback